Immunoprecise Antibodies Ltd
Stock Chart, Company Information, and Scan Results
$2.70(as of Aug 18, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Immunoprecise Antibodies Ltd Company Information, Fundamentals, and Technical Indicators
Stock Price$2.70
Ticker SymbolIPA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees81
CountyUSA
Market Cap$92.3M
EBIDTA-9.3M
P/E Ratio-2.96
Forward P/E Ratio0.00
Earnings per Share-0.66
Profit Margin-30.96%
RSI72.97
Shares Outstanding46.2M
ATR0.24
52-Week High2.72
Volume9,560,754
52-Week Low0.27
Book Value23.6M
P/B Ratio3.78
Upper Keltner2.48
P/S Ratio3.65
Lower Keltner1.40
Next Earnings DateUnknown
Cash Surplus1.7M
Next Ex-Dividend DateUnknown
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Immunoprecise Antibodies Ltd In Our Stock Scanner
As of Aug 19, 2025
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.